Emerging data have established that GLP-1 agonist administration has not increased the risk of malignancy outside of the thyroid gland and may in fact reduce the risk of malignancy with potential for preventive applications [203,204]
Journal of Neurochemistry 65:23772380
Understanding how dosing works helps you make informed decisions about your treatment plan
For hospitalization and ED visits, the IRs were 210.4 and 150.9 in GLP-1RA users, compared with 231.3 and 193 in non-users, respectively
Reviewing the team's patent and related documents at Talpos's request, Anna Mapp, the Edwin Vedejs Collegiate Professor of Chemistry at the University of Michigan, and also the President of the American Peptide Society, questioned the limited detail available and the absence of a published sequence for the peptide's parent protein, an omission she noted makes the original work impossible to reproduce